81 related articles for article (PubMed ID: 17899084)
41. Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches.
Dumont F; Altmeyer A; Bischoff P
Expert Opin Ther Pat; 2009 Jun; 19(6):775-99. PubMed ID: 19456277
[TBL] [Abstract][Full Text] [Related]
42. Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy.
Twigger K; Vidal L; White CL; De Bono JS; Bhide S; Coffey M; Thompson B; Vile RG; Heinemann L; Pandha HS; Errington F; Melcher AA; Harrington KJ
Clin Cancer Res; 2008 Feb; 14(3):912-23. PubMed ID: 18245555
[TBL] [Abstract][Full Text] [Related]
43. [Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro].
Deng G; Yu JH; Ye ZQ; Hu ZQ
Zhonghua Nan Ke Xue; 2008 Feb; 14(2):116-21. PubMed ID: 18390174
[TBL] [Abstract][Full Text] [Related]
44. Induction of cell cycle arrest in human MCF-7 breast cancer cells by cis-stilbene derivatives related to VIOXX.
Sangjun S; de Jong E; Nijmeijer S; Mutarapat T; Ruchirawat S; van den Berg M; van Duursen MB
Toxicol Lett; 2009 Apr; 186(2):115-22. PubMed ID: 19429232
[TBL] [Abstract][Full Text] [Related]
45. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
Hsu YL; Kuo PL; Tzeng TF; Sung SC; Yen MH; Lin LT; Lin CC
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e290-9. PubMed ID: 18522681
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
Lei XS; Yu XD; Yin L; Liu ZH; Tang PC
Bioorg Med Chem Lett; 2008 Aug; 18(16):4602-5. PubMed ID: 18653334
[TBL] [Abstract][Full Text] [Related]
47. 4'-methoxy-2-styrylchromone a novel microtubule-stabilizing antimitotic agent.
Marinho J; Pedro M; Pinto DC; Silva AM; Cavaleiro JA; Sunkel CE; Nascimento MS
Biochem Pharmacol; 2008 Feb; 75(4):826-35. PubMed ID: 18036572
[TBL] [Abstract][Full Text] [Related]
48. Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells.
Thati B; Noble A; Creaven BS; Walsh M; McCann M; Devereux M; Kavanagh K; Egan DA
Eur J Pharmacol; 2009 Jan; 602(2-3):203-14. PubMed ID: 19041861
[TBL] [Abstract][Full Text] [Related]
49. [Combined effect of iodine compounds and Cs137 gamma rays on yeast cells].
Seliverstova LA; Vakina IP; Meĭsel' MN; Mokhnach VO
Izv Akad Nauk SSSR Biol; 1974; (1):129-31. PubMed ID: 4461736
[No Abstract] [Full Text] [Related]
50. [On the radiosensitising action of deoxyribonuclease].
Carcò FP; Giraldi M; Gorini S; Colloi D
Arch De Vecchi Anat Patol; 1967 Jun; 49(1):55-63. PubMed ID: 5606190
[No Abstract] [Full Text] [Related]
51. Studies of the toxicity and radiosensitising activity of triacetoneamine-N-oxyl in mice.
Hewitt HB; Blake ER
Br J Radiol; 1970 Feb; 43(506):91-6. PubMed ID: 5424290
[No Abstract] [Full Text] [Related]
52. Definition of the cell cycle segment with special sensitivity to vinblastine.
Chirife AM; Studzinski GP
Proc Soc Exp Biol Med; 1978 Feb; 157(2):206-10. PubMed ID: 622386
[No Abstract] [Full Text] [Related]
53. Urothelial carcinoma: vinflunine offers modest but important survival benefit.
Razzak M
Nat Rev Urol; 2013 Apr; 10(4):186. PubMed ID: 23459036
[No Abstract] [Full Text] [Related]
54. Urological cancer: Vinflunine is an effective maintenance therapy.
Sidaway P
Nat Rev Clin Oncol; 2017 Jun; 14(6):328. PubMed ID: 28466878
[No Abstract] [Full Text] [Related]
55. The taccalonolides, novel microtubule stabilizers, and γ-radiation have additive effects on cellular viability.
Risinger AL; Natarajan M; Thomas CR; Mooberry SL
Cancer Lett; 2011 Aug; 307(1):104-111. PubMed ID: 21507571
[TBL] [Abstract][Full Text] [Related]
56. Further mechanistic unravelling of the influence of the cell cycle effects on the radiosensitising mechanism of vinflunine, in vitro.
Simoens C; Pauwels B; Vermorken JB; Pattyn GG; Lambrechts HA; Breillout F; Lardon F
Cancer Chemother Pharmacol; 2008 Jul; 62(2):183-93. PubMed ID: 17899084
[TBL] [Abstract][Full Text] [Related]
57. Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro.
Simoens C; Vermorken JB; Korst AE; Pauwels B; De Pooter CM; Pattyn GG; Lambrechts HA; Breillout F; Lardon F
Cancer Chemother Pharmacol; 2006 Aug; 58(2):210-8. PubMed ID: 16317558
[TBL] [Abstract][Full Text] [Related]
58. The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro.
Pauwels B; Korst AE; Lambrechts HA; Pattyn GG; de Pooter CM; Lardon F; Vermorken JB
Cancer Chemother Pharmacol; 2006 Aug; 58(2):219-28. PubMed ID: 16331496
[TBL] [Abstract][Full Text] [Related]
59. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
Jordan MA; Horwitz SB; Lobert S; Correia JJ
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
[TBL] [Abstract][Full Text] [Related]
60. Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro.
Simoens C; Lardon F; Pauwels B; De Pooter CM; Lambrechts HA; Pattyn GG; Breillout F; Vermorken JB
BMC Cancer; 2008 Feb; 8():65. PubMed ID: 18312675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
